Marianne Chase

1.1k total citations
10 papers, 148 citations indexed

About

Marianne Chase is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Marianne Chase has authored 10 papers receiving a total of 148 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pathology and Forensic Medicine, 3 papers in Neurology and 2 papers in Rheumatology. Recurrent topics in Marianne Chase's work include Multiple Sclerosis Research Studies (3 papers), Amyotrophic Lateral Sclerosis Research (3 papers) and Ethics in Clinical Research (2 papers). Marianne Chase is often cited by papers focused on Multiple Sclerosis Research Studies (3 papers), Amyotrophic Lateral Sclerosis Research (3 papers) and Ethics in Clinical Research (2 papers). Marianne Chase collaborates with scholars based in United States, United Kingdom and Japan. Marianne Chase's co-authors include Andrew Goodman, Robert J. Fox, Eric C. Klawiter, Robert Bermel, Robert T. Naismith, Melanie Quintana, Michelle A. Detry, Sabrina Paganoni, Eric A. Macklin and Hong Yu and has published in prestigious journals such as PLoS ONE, Neurology and Annals of Neurology.

In The Last Decade

Marianne Chase

8 papers receiving 147 citations

Peers

Marianne Chase
Boaz Lahav Canada
Aram Zabeti United States
Lan Pham United States
Tobias Moll United Kingdom
Erik van Munster Netherlands
Anna‐Leigh Brown United States
Boaz Lahav Canada
Marianne Chase
Citations per year, relative to Marianne Chase Marianne Chase (= 1×) peers Boaz Lahav

Countries citing papers authored by Marianne Chase

Since Specialization
Citations

This map shows the geographic impact of Marianne Chase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marianne Chase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marianne Chase more than expected).

Fields of papers citing papers by Marianne Chase

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marianne Chase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marianne Chase. The network helps show where Marianne Chase may publish in the future.

Co-authorship network of co-authors of Marianne Chase

This figure shows the co-authorship network connecting the top 25 collaborators of Marianne Chase. A scholar is included among the top collaborators of Marianne Chase based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marianne Chase. Marianne Chase is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Chaudhuri, Shomesh E., et al.. (2025). Financing drug development via adaptive platform trials. PLoS ONE. 20(7). e0325826–e0325826.
2.
Quintana, Melanie, Benjamin R. Saville, Michelle A. Detry, et al.. (2023). Design and Statistical Innovations in a Platform Trial for Amyotrophic Lateral Sclerosis. Annals of Neurology. 94(3). 547–560. 19 indexed citations
3.
Chase, Marianne, et al.. (2022). Mobilizing the clinical trial ecosystem to drive adoption of master protocols. Clinical Trials. 19(6). 690–696. 1 indexed citations
4.
Paganoni, Sabrina, James D. Berry, Melanie Quintana, et al.. (2021). Adaptive Platform Trials to Transform Amyotrophic Lateral Sclerosis Therapy Development. Annals of Neurology. 91(2). 165–175. 46 indexed citations
5.
Goodman, Andrew, Jon Yankey, Elizabeth Klingner, et al.. (2021). Response to ibudilast treatment according to progressive multiple sclerosis disease phenotype. Annals of Clinical and Translational Neurology. 8(1). 111–118. 12 indexed citations
6.
Fox, Robert J., Paola Raska, Christian Barro, et al.. (2021). Neurofilament light chain in a phase 2 clinical trial of ibudilast in progressive multiple sclerosis. Multiple Sclerosis Journal. 27(13). 2014–2022. 33 indexed citations
7.
Bermel, Robert, Peter K. Kaiser, Elizabeth Klingner, et al.. (2020). Optical coherence tomography outcomes from SPRINT-MS, a multicenter, randomized, double-blind trial of ibudilast in progressive multiple sclerosis. Multiple Sclerosis Journal. 27(9). 1384–1390. 20 indexed citations
8.
Fox, Robert J., Janel Barnes, Marianne Chase, et al.. (2018). A Phase II Trial of Ibudilast in Progressive Multiple Sclerosis (CT.004). Neurology. 90(15_supplement). 1 indexed citations
9.
Fukushima, Masanori, Christopher Austin, Norihiro Sato, et al.. (2018). The Global academic research organization network: Data sharing to cure diseases and enable learning health systems. Learning Health Systems. 3(1). e10073–e10073. 10 indexed citations
10.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026